Answers are grounded in this paper and cite their sources.
Microcystin-LR (MC-LR) treatment benefits from rapid parent removal and control of transformation products. We co-immobilized cell-free MlrA and MlrC preparations on chitosan- and glutaraldehyde-functionalized magnetic biochar to form a dual-enzyme magnetic biochar composite (DMBC). At 1 mg·L−1 MC-LR, measured removal reached 82.85 ± 0.26% within 30 min and 95.28 ± 0.34% within 1 h. No difference in 30 min removal was detected between DMBC and the MlrA-only composite (80.00 ± 5.66%). MlrC-only and induced empty-vector BL21 lysate composites gave similar lower responses, indicating a substantial carrier-associated contribution. Linear MC-LR and 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4(E),6(E)-dienoic acid (Adda) were identified in recovered DMBC extracts. Linear MC-LR was also detected qualitatively in recovered MlrA-only material. Together, these observations are consistent with the established MlrA/MlrC cleavage sequence. A separate Adda experiment showed a 97.02 ± 4.22% decrease in normalized aqueous chromatographic response at 30 min. Six weekly reuse cycles maintained mean MC-LR removal between 74.60% and 81.50%. Treatment of centrifuged urban lake water showed concentration-dependent removal at 60 min. The results support a reusable cell-free treatment material that combines MlrA-associated transformation and carrier-associated removal, with product evidence consistent with downstream cleavage.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: